Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition

被引:98
作者
Mason, JC
Yarwood, H
Sugars, K
Morgan, BP
Davies, KA
Haskard, DO
机构
[1] Hammersmith Hosp, Natl Heart & Lung Inst, Imperial Coll, Sch Technol & Med,BHF Cardiovasc Med Unit, London W12 0NN, England
[2] Cardiff Univ, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales
关键词
D O I
10.1182/blood.V94.5.1673.417a05_1673_1682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelium is continuously exposed to complement-mediated challenge, and this is enhanced during inflammation. Although the complement-regulatory proteins decay-accelerating factor (DAF), CD59, and membrane cofactor protein (MCP) protect endothelial cells (ECs) against complement-mediated injury, the control of their expression and relative contributions to vascular protection is unclear, We explored the hypothesis that mechanisms exist which induce upregulation of complement-regulatory proteins on ECs to maintain vascular function in inflammation. Tumor necrosis factor alpha (TNF alpha) and interferon gamma (IFN gamma) each increased DAF expression but not CD59 or MCP expression, and a combination of these cytokines was more potent than either alone. Cytokine-induced expression depended on increased DAF mRNA and de novo protein synthesis and was maximal by 72 hours. In addition, assembly of the membrane-attack complex (MAC) on ECs induced a 8-fold increase in DAF expression, and this was enhanced by cytokines. DAF upregulation was not inhibited by protein kinase C (PKC) antagonists. The increase in DAF was functionally relevant since it reduced complement 3 (C3) deposition by 40%, and this was inhibited by an anti-DAF monoclonal antibody, These observations indicate that upregulation of DAF expression by cytokines or MAC may represent an important feedback mechanism to maintain the integrity of the microvasculature during subacute and chronic inflammatory processes involving complement activation. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:1673 / 1682
页数:10
相关论文
共 58 条
  • [1] HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE
    ADES, EW
    CANDAL, FJ
    SWERLICK, RA
    GEORGE, VG
    SUMMERS, S
    BOSSE, DC
    LAWLEY, TJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) : 683 - 690
  • [2] DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
    ASCH, AS
    KINOSHITA, T
    JAFFE, EA
    NUSSENZWEIG, V
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) : 221 - 226
  • [3] ASGHAR SS, 1995, LAB INVEST, V72, P254
  • [4] Protective genes expressed in endothelial cells: a regulatory response to injury
    Bach, FH
    Hancock, WW
    Ferran, C
    [J]. IMMUNOLOGY TODAY, 1997, 18 (10): : 483 - 486
  • [5] TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS
    BENZAQUEN, LR
    NICHOLSONWELLER, A
    HALPERIN, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) : 985 - 992
  • [6] BHAKDI S, 1988, J IMMUNOL, V141, P3117
  • [7] RENAL LOCALIZATION OF THE MEMBRANE ATTACK COMPLEX IN SYSTEMIC LUPUS-ERYTHEMATOSUS NEPHRITIS
    BIESECKER, G
    KATZ, S
    KOFFLER, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (06) : 1779 - 1794
  • [8] BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
  • [9] RELATIVE ROLES OF DECAY-ACCELERATING FACTOR, MEMBRANE COFACTOR PROTEIN, AND CD59 IN THE PROTECTION OF HUMAN ENDOTHELIAL-CELLS AGAINST COMPLEMENT-MEDIATED LYSIS
    BROOIMANS, RA
    VANWIERINGEN, PAM
    VANES, LA
    DAHA, MR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) : 3135 - 3140
  • [10] BRYANT RW, 1990, J IMMUNOL, V144, P593